Association Between the Use of Fondaparinux vs Low-Molecular-Weight Heparin and Clinical Outcomes in Patients With Non–ST-Segment Elevation Myocardial Infarction
Conclusions and RelevanceIn routine clinical care of patients with NSTEMI, fondaparinux was associated with lower odds than LMWH of major bleeding events and death both in-hospital and up to 180 days afterward.
Source: JAMA - Category: Journals (General) Source Type: research
More News: Bleeding | Cardiology | Clinical Trials | General Medicine | Heart | Heart Attack | Heart Disease | Stroke | Study